LANSING, Mich. (Great Lakes News) – Pfizer announced early Tuesday that a study is underway comparing its original COVID-19 vaccine with doses specially tweaked to match the Omicron variant.
The Omicron variant has been described by health officials as a more contagious variant with less severe symptoms.
MORE NEWS: Pro-Palestinian Tent City Pops Up on University of Michigan Campus
COVID-19 vaccine makers have been updating their shots to better match Omicron if global health authorities decide the change is needed.
Leave a Comment
COMMENTS POLICY: We have no tolerance for messages of violence, racism, vulgarity, obscenity or other such discourteous behavior. Thank you for contributing to a respectful and useful online dialogue.